chr4-89909310-C-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The ENST00000264790.7(MMRN1):c.658C>A(p.Pro220Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000311 in 1,609,680 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000027 ( 0 hom. )
Consequence
MMRN1
ENST00000264790.7 missense
ENST00000264790.7 missense
Scores
1
9
9
Clinical Significance
Conservation
PhyloP100: 4.47
Genes affected
MMRN1 (HGNC:7178): (multimerin 1) Multimerin is a massive, soluble protein found in platelets and in the endothelium of blood vessels. It is comprised of subunits linked by interchain disulfide bonds to form large, variably sized homomultimers. Multimerin is a factor V/Va-binding protein and may function as a carrier protein for platelet factor V. It may also have functions as an extracellular matrix or adhesive protein. Recently, patients with an unusual autosomal-dominant bleeding disorder (factor V Quebec) were found to have a deficiency of platelet multimerin. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.801
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MMRN1 | NM_007351.3 | c.658C>A | p.Pro220Thr | missense_variant | 2/8 | ENST00000264790.7 | NP_031377.2 | |
MMRN1 | NM_001371403.1 | c.658C>A | p.Pro220Thr | missense_variant | 3/9 | NP_001358332.1 | ||
MMRN1 | XM_047449831.1 | c.658C>A | p.Pro220Thr | missense_variant | 3/8 | XP_047305787.1 | ||
MMRN1 | NM_001410735.1 | c.-117C>A | 5_prime_UTR_variant | 2/8 | NP_001397664.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MMRN1 | ENST00000264790.7 | c.658C>A | p.Pro220Thr | missense_variant | 2/8 | 1 | NM_007351.3 | ENSP00000264790 | P1 | |
MMRN1 | ENST00000394980.5 | c.658C>A | p.Pro220Thr | missense_variant | 3/9 | 5 | ENSP00000378431 | P1 | ||
MMRN1 | ENST00000508372.1 | c.-117C>A | 5_prime_UTR_variant | 2/8 | 2 | ENSP00000426461 |
Frequencies
GnomAD3 genomes AF: 0.00000661 AC: 1AN: 151378Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
151378
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1458302Hom.: 0 Cov.: 30 AF XY: 0.00000276 AC XY: 2AN XY: 725486
GnomAD4 exome
AF:
AC:
4
AN:
1458302
Hom.:
Cov.:
30
AF XY:
AC XY:
2
AN XY:
725486
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000661 AC: 1AN: 151378Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 73892
GnomAD4 genome
AF:
AC:
1
AN:
151378
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
73892
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 15, 2024 | The c.658C>A (p.P220T) alteration is located in exon 2 (coding exon 2) of the MMRN1 gene. This alteration results from a C to A substitution at nucleotide position 658, causing the proline (P) at amino acid position 220 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D
MetaSVM
Benign
T
MutationAssessor
Benign
N;N
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Uncertain
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
D;D
Vest4
MutPred
Gain of catalytic residue at P220 (P = 0.0134);Gain of catalytic residue at P220 (P = 0.0134);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at